Revelation Biosciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Revelation Biosciences, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 1,342,247% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than almost all Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, is 4.8 times its market value (net cash). Higher than almost all Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 96% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-359.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 96% of Healthcare companies in United States.
Cash Cushion Ratio
4.8× cashCash, after subtracting all debt, is 4.8 times its market value (net cash).
Higher than almost all Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Revelation Biosciences, Inc. owes $0.19 for every $1 it owns. Revelation Biosciences, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
0.1Investors pay $0.1 for every $1 of Revelation Biosciences, Inc.'s yearly profit, lower than 96% of Healthcare companies in United States.
P/B ratio
0.21The share price is 0.21 times Revelation Biosciences, Inc.'s book value per share, lower than 98% of Healthcare companies in United States.
Market cap
$2 MThe total market value of all of Revelation Biosciences, Inc.'s shares at today's price (share price × number of shares), smaller than 98% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$10 MWhat Revelation Biosciences, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$17.69Net worth divided by the number of shares. The share price of $3.68 is 0.2 times this, which is the P/B above.
Return on equity (ROE)
-154.8%Revelation Biosciences, Inc. lost 154.8% of its shareholders' money over the last year, lower than 80% of Healthcare companies in United States.
Owes vs Owns
0.19×Revelation Biosciences, Inc. owes $0.19 for every $1 it owns (low), lower than 73% of Healthcare companies in United States.
Dividend yield
NoneRevelation Biosciences, Inc. does not currently pay a dividend.
Profit growth
LossRevelation Biosciences, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashRevelation Biosciences, Inc. held $10 M more cash than debt (net cash) at Dec 2025.
Questions
What is Revelation Biosciences, Inc.'s P/E ratio?
Investors pay $0.1 for every $1 of Revelation Biosciences, Inc.'s yearly profit, lower than 96% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Revelation Biosciences, Inc.: $2 M ÷ $10 M (30 Jun 2026) = 0.2.
What is Revelation Biosciences, Inc.'s return on equity?
Revelation Biosciences, Inc. lost 154.8% of its shareholders' money over the last year, lower than 80% of Healthcare companies in United States.
How much does Revelation Biosciences, Inc. owe compared with what it owns?
Revelation Biosciences, Inc. owes $0.19 for every $1 it owns (low), lower than 73% of Healthcare companies in United States.
Does Revelation Biosciences, Inc. pay a dividend?
No. Revelation Biosciences, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.